THREE-YEAR RESULTS FOR EYLEA HD® (AFLIBERCEPT) INJECTION 8 MG DEMONSTRATE CONTINUED DURABLE VISION GAINS AND ANATOMIC IMPROVEMENTS WITH EXTENDED DOSING INTERVALS IN PATIENTS WITH DIABETIC MACULAR EDEMA

Reuters · 10/18 21:05

Please log in to view news